Stocks surged higher on Monday after it appears that the trade war risks may have been somewhat overblown. Stocks were indicated to open higher on Tuesday as well. The bull market is now over nine years old and the trend that has prevailed so far has been for investors to buy the pullbacks. Investors are still trying to decide how they want their allocations positioned for the rest of 2018 and beyond.
24/7 Wall St. reviews dozens of analyst research reports each day of the week in an effort to find new ideas for investors and traders alike. Some of the daily analyst and research reports cover stocks to buy. Others cover stocks to sell or to avoid.
Additional color and commentary has been added on most of the daily analyst reports. The consensus analyst price targets and other valuation metrics are from the Thomson Reuters sell-side research service.
These were the top analyst upgrades, downgrades and other research calls from Tuesday, March 27, 2018.
Adamas Pharmaceuticals Inc. (NASDAQ: ADMS) was started with a Buy rating and assigned a $39 price objective (versus a $24.40 prior close) at Merrill Lynch.
Albemarle Corp. (NYSE: ALB) was maintained as Buy but the price target was cut to $125 from $148 (versus a $94.36 close) at Argus. The independent research firm said the cut is based on a reduction in its long-term EPS growth forecast.
American Axle & Manufacturing Holdings Inc. (NYSE: AXL) was raised to Buy from Neutral with a $20 price target (versus a $15.34 close) at Citigroup.
AnaptysBio Inc. (NASDAQ: ANAB) was reiterated as Outperform with a $151 price target (versus a $113.83 close) at Wedbush Securities.
Aratana Therapeutics Inc. (NASDAQ: PETX) was raised to Buy from Hold with an $8 price target (versus a $3.87 close) at Stifel.
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) was started with a Buy rating and assigned a $10 price target (versus a $6.94 close) at Jefferies.
BB&T Corp. (NYSE: BBT) was raised to Buy from Neutral with a $59 price target (versus a $52.22 close) at B. Riley. Wells Fargo raised it to Outperform from Market Perform and has a $63 price target.
Brookfield Property Partners L.P. (NYSE: BPY) was raised to Buy from Hold with a $24 price target (versus a $19.39 close) at Canaccord Genuity.
Canadian Solar Inc. (NASDAQ: CSIQ) was downgraded to Underweight from Neutral but the price target was maintained at $17 (versus a $17.51 close) at JPMorgan. Canadian Solar was indicated down 3% at $16.99, and it has a 52-week trading range of $11.31 to $19.09 and a consensus analyst price target of $19.40.
Cheniere Energy Inc. (NYSEAMERICAN: LNG) was raised to Outperform from Market Perform with a $63 price target (versus a $52.51 close) at Bernstein.
Cheniere Energy Partners L.P. (NYSEAMERICAN: CQP) was raised to Outperform from Market Perform with a $35 price target (versus a $28.16 close) at Bernstein.
Chesapeake Energy Corp. (NYSE: CHK) was downgraded to Underperform from Market Perform and the price target was cut to $2.50 from $4.00 at Bernstein. Shares closed up 1.6% at $3.12 on Monday and were down 0.6% at $3.10 on Tuesday, in a 52-week range of $2.53 to $6.59 and with a consensus price target of $4.13.
Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.